Next Biometrics Group ASA (OSTO:NEXTO) ROCE %: -1,216.44% (As of Mar. 2026)

What is Next Biometrics Group ASA ROCE %?

Next Biometrics Group ASA OSTO:NEXTO 33 ROCE % is -1,216.44% as of Mar. 2026. GuruFocus rates OSTO:NEXTO with a GF Score™ of 33/100 and a GF Value™ of kr37.70. The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Next Biometrics Group ASA's annualized ROCE % for the quarter that ended in Mar. 2026 was -1,216.44%.

Next Biometrics Group ASA (OSTO:NEXTo) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Next Biometrics Group ASA ROCE % Related Terms

Next Biometrics Group ASA ROCE % Historical Data

* Premium members only.

The historical data trend for Next Biometrics Group ASA's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Next Biometrics Group ASA ROCE % Chart

Next Biometrics Group ASA Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

-48.30

-39.62

-67.97

-82.35

-141.62

Next Biometrics Group ASA Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															-72.26	-93.76	-150.47	-396.85	-1,216.44

33GF Score

Next Biometrics Group ASA OSTO:NEXTO

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Next Biometrics Group ASA ROCE % Calculation

Next Biometrics Group ASA's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	-80.155	/	( ( (116.676 - 29.653)	+	(49.269 - 23.095) )	/ 2 )
	=	-80.155	/	( (87.023	+	26.174)	/ 2 )
	=	-80.155	/	56.5985
	=	-141.62 %

Next Biometrics Group ASA's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	-124.904	/	( ( (49.269 - 23.095)	+	(34.202 - 39.84) )	/ 2 )
	=	-124.904	/	( ( 26.174	+	-5.638 )	/ 2 )
	=	-124.904	/	10.268
	=	-1,216.44 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of -1,216.44% mean?

Next Biometrics Group ASA (OSTO:NEXTO) has a ROCE % of -1,216.44% as of Mar. 2026.

Is Next Biometrics Group ASA's ROCE % too high?

Next Biometrics Group ASA's current ROCE % is -1,216.44%. Overall, Next Biometrics Group ASA has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.

How does Next Biometrics Group ASA's ROCE % compare to COHR and KEYS?

Next Biometrics Group ASA's ROCE % of -1,216.44% can be compared against companies in the Hardware industry. The industry median ROCE % is 5.83. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Hardware company?

The median ROCE % among Hardware companies is 5.83, based on 2,445 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Hardware industry, the median ROCE % is 5.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Next Biometrics Group ASA's current ROCE % is -1,216.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Next Biometrics Group ASA stock overvalued right now?

Next Biometrics Group ASA (OSTO:NEXTO) has a current ROCE % of -1,216.44%. The stock's GF Value™ is kr37.70, compared to a current price of kr9.64 — trading 74.4% below its estimated fair value. The current ROCE % is -1,216.44%. Next Biometrics Group ASA's overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Next Biometrics Group ASA (OSTO:NEXTO), the current ROCE % is -1,216.44% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Next Biometrics Group ASA (OSTO:NEXTO) Overvalued in 2026?

Based on GuruFocus' analysis, Next Biometrics Group ASA stock appears to be undervalued. The current stock price of kr9.64 is trading 74.4% below its estimated GF Value™ of kr37.70.

Key valuation signals for OSTO:NEXTO:

ROCE %: -1,216.44%
GF Value™: kr37.70 vs. price of kr9.64 (74.4% below fair value)
GF Score™: 33/100 with 5 warning signs

No single metric tells the full story. See the OSTO:NEXTO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Next Biometrics Group ASA Business Description

Industry Technology Hardware

Comparable Companies TSE:6861 COHR KEYS GRMN TPE:2360 TDY OSTO:HEXA B MKSI FTV TRMB CGNX SZSE:002414 SZSE:300567 ESE ST TSE:6856 TSE:7701 NOVT ASX:CDA LSE:RSW

Other Exchanges NEXT:Norway 0QWK:UK

Address Stortorvet 7, Oslo, NOR, 0155

Website https://www.nextbiometrics.com

Next Biometrics Group ASA provides fingerprint sensor technology and products. The company's products are utilized for Smart Card, Government ID, Access control, Notebook, and others. The company's products include smart card solutions, fingerprint sensor modules, fingerprint readers, Aadhar products, Software DevKits, and Hardware DevKits. The company has one operating segment namely; Fingerprint sensor Technology. The company's Geographic customer base consists of Asia (Japan and India), Europe (France and Germany) and North America.

33GF Score

Get the complete analysis for OSTO:NEXTO

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr9.64

Price

kr37.70

GF Value

View OSTO:NEXTO Analysis

See ROCE % data for all stocks →